Efficacy of Verciguat in TR and RV Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.
Also called NCT07668739
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT07668739
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07668739. Randomized; no masking; primary purpose treatment. Start 2026-07-01 (anticipated); primary completion 2028-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Verciguat in TR and RV Failure
- Acronym
- VERT-HF
- Condition
- HFrEF
- Condition
- Tricuspid Regurgitation (TR)
- Intervention (Drug)
- Vericiguat
- Lead sponsor
- Daejeon St. Mary's hospital
- Collaborator
- Seoul St. Mary's Hospital
- Collaborator
- Uijeongbu St. Mary Hospital
- Collaborator
- Incheon St.Mary's Hospital
Record details
- Record id
cardio:ct-nct07668739- Content hash
a6c971e11f1fb4cb3c3166d168255fd0c0a48be2ae14268e3e6ad8437a263c57